Retatrutide refers to a peptide known as LY3437943, which acts on three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)
Upon injury, the bodys innate immune system attempts to defend against microbial invasion
[DOI] [PubMed] [Google Scholar] 47.Cigliola V, Thorel F, Chera S, Herrera PL
Consume Responsibly: Not recommended for children, people sensitive to caffeine, pregnant women or women who are nursing
The FDA still has specific criteria a substance must meet to be eligible for compounding, and the PCACs July 2026 review will determine whether any of these peptides will be officially cleared